Granted Patent
B2
US 6,841,156 · App. 09/904,057 · Granted Jan 11, 2005
Method for treating muscle spasm with botulinum toxin type B
Assignee:
Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Claims (1)
1. A method for treating a strabismus, the method comprising the step of administering to a human patient a therapeutically effective amount of botulinum toxin type B to treat strabismus, wherein the botulinum toxin type B is administered by intramuscular injection or by subcutaneous injection, and the administration of the botulinum toxin type B results in alleviation of the strabismus within 1 day to 7 days.
Assignments (5)
RELEASE OF SECURITY INTEREST
Recorded Oct 14, 2014
From: JPMORGAN CHASE BANK, N.A.
To: SOLSTICE NEUROSCIENCES, LLC
Reel/Frame 033987/0440 →
SECURITY AGREEMENT
Recorded Sep 26, 2012
From: SOLSTICE NEUROSCIENCES, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 029041/0720 →
MERGER
Recorded Sep 6, 2012
From: SOLSTICE NEUROSCIENCES, INC.
To: SOLSTICE NEUROSCIENCES, LLC
Reel/Frame 028917/0475 →
RELEASE AND REASSIGNMENT
Recorded Aug 10, 2010
From: NEXBANK, SSB
To: SOLSTICE NEUROSCIENCES, INC.
Reel/Frame 024812/0653 →
SECURITY AGREEMENT
Recorded Mar 6, 2007
From: SOLSTICE NEUROSCIENCES, INC.
To: NEXBANK, SSB
Reel/Frame 018969/0513 →
Continuity (4)